Skip to main content
. 2017 Oct 19;8:179–190. doi: 10.2147/LCTT.S139647

Table 2.

Incidence of adverse events

Adverse events, % nab-Paclitaxel plus carboplatin
(n = 61)
Gemcitabine plus carboplatin
(n = 132)
P-value
Hematologic
Anemia 62 66 0.63
 Grade 3/4 10 26 0.01
Neutropenia 51 56 0.54
 Grade 3/4 2 11 0.04
Thrombocytopeniaa 16 23 0.34
Non-hematologic (grade not specified)
Nausea 89 73 0.01
Pain 79 79 0.99
Vomiting 61 58 0.69
Fatigue 62 63 0.94
Diarrhea 59 48 0.15
Mucositis 25 31 0.36
Neuropathy 30 12 < 0.01
Dehydration 25 17 0.20

Note:

a

Not able to calculate grade 3 and 4 thrombocytopenia due to low incidence and/or missing lab values.